Thursday, August 03, 2017

Rider from Bahrain suspended and fined over endurance horse’s positive drug test

Horsetalk.co.nz - Full Article

August 2, 2017
Horsetalk.co.nz

A rider from Bahrain has been suspended from competition for six months and fined 2000 Swiss francs after his endurance mount tested positive to five substances not permitted under FEI equine anti-doping rules.

The Bahrain-registered horse Ultreia Larzac, ridden by Othman Abduljaleel Al Awadhi, competed in the CEI2* 120km ride at the Bahrain International Endurance Village, Sakhir, on January 14 this year.

The horse was selected for drug testing. The blood sample revealed the presence of caffeine, theophylline, phenylbutazone, oxyphenbutazone, and dexamethasone.

Caffeine is a central nervous system stimulant. Theophylline is used to open airways in the treatment of respiratory disease. Phenylbutazone and its metabolic byproduct oxyphenbutazone are non-steroidal anti-inflammatory drugs with painkilling effects. Dexamethasone is a corticosteroid drug with anti-inflammatory effects...

Read more at https://www.horsetalk.co.nz/2017/08/02/rider-bahrain-suspension-fine-endurance-horse/#OoSjzXMdLBQybC4j.99

By -

FEI Goes Quiet on Sanctions Against Countries with a Doping Problem

HorseSport.com - Full Article After a huge spike in positives in Saudi Arabia, last year the FEI told HorseSport.com it would discuss a co...